Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.

Autor: de Oliveira Ascef, Bruna¹ (AUTHOR) brunaascef16@gmail.com, Almeida, Matheus Oliveira² (AUTHOR), de Medeiros-Ribeiro, Ana Cristina³ (AUTHOR), de Oliveira Andrade, Danieli Castro³ (AUTHOR), de Oliveira Junior, Haliton Alves² (AUTHOR), de Soárez, Patrícia Coelho⁴ (AUTHOR)

Publikováno v: Scientific Reports. 11/18/2023, Vol. 13 Issue 1, p1-14. 14p.

PROGNOSTIC MODELING STUDIES FOR PREDICTING LEPROSY CASES: PROTOCOL FOR A SCOPING REVIEW

Autor: DE OLIVEIRA ASCEF, BRUNA, de Oliveira Júnior, Haliton

Background: Leprosy is a neglected tropical disease caused by Mycobacterium leprae that mainly affects the skin, the peripheral nerves, mucosa of the upper respiratory tract, and the eyes. Mathematical models and statistical methodology could have a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a55c342fbd5f4fd8f6be41c991e0c54

Health-related quality of life of patients of Brazilian primary health care.

Autor: de Oliveira Ascef, Bruna, Haddad, João Paulo Amaral, Álvares, Juliana, Guerra Junior, Augusto Afonso, Costa, Ediná Alves, de Assis Acurcio, Francisco, Guibu, Ione Aquemi, Costa, Karen Sarmento, de Oliveira Karnikowski, Margô Gomes, Soeiro, Orlando Mario, Leite, Silvana Nair, Silveira, Micheline Rosa

Publikováno v: Revista de Saúde Pública; 2017, Vol. 51 Issue Suppl2, p1s-12s, 12p

Methodological guidelines and publications of benefit-risk assessment for health technology assessment: a scoping review protocol.

Autor: De Oliveira Ascef B; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil brunaascef16@gmail.com., Gabriel FC; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil., Suzumura EA; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL, University for Health Sciences and Technology, Hall, Austria., Maia FHA; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil., Bortoluzzi AFR; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil., Farias NS; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil., Jahn B; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL, University for Health Sciences and Technology, Hall, Austria., Siebert U; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL, University for Health Sciences and Technology, Hall, Austria., De Soarez PC; Departamento de Medicina Preventiva, Faculdade de Medicina, FMUSP, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.

Publikováno v: BMJ open [BMJ Open] 2023 Dec 10; Vol. 13 (12), pp. e075333. Date of Electronic Publication: 2023 Dec 10.